One injection could keep osteoarthritis drugs working for weeks
Scientists have developed an injectable gel that stays in arthritic joints for weeks, slowly releasing medication and improving lubrication. The gel could make treatment more effective and reduce the need for frequent injections. It uses a biocompatible material that changes from liquid to semisolid at body temperature and releases drugs over time.
A new injectable gel stays in joints for weeks, releasing medication and improving lubrication. It changes from liquid to semisolid at body temperature and can hold and slowly release drugs.
This could improve treatment for osteoarthritis by making medication last longer and reducing the need for repeated injections. It may also help deliver drugs that target the disease itself, not just symptoms.
The development offers a practical solution that could ease patient discomfort and improve long-term outcomes. It shows progress in making medical treatments more efficient and targeted.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.